Search

everythinglearnresearchcommunity

for

Search:↓

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

Gefitinib can cause rare scarring hair loss.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Topical Ruxolitinib may safely treat severe hair loss.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Tofacitinib taken by mouth helps treat hair loss in children.